Skip to main content
View expanded cover

Burkitt’s Lymphoma pp 95–119Cite as

Endemic Burkitt’s Lymphoma

  • 944 Accesses

Part of the Current Cancer Research book series (CUCR)

Abstract

Endemic Burkitt’s lymphoma is the most common childhood tumour in parts of the world where malaria is holo-endemic. It is highly chemo-sensitive and cure rates are excellent if treated early and aggressively. Unfortunately many children arrive late and live where neither the treatment nor the supportive care is optimal.

The presentation and complications of endemic Burkitt’s lymphoma and complications and protocols of varying intensity used to treat these children with their outcomes are presented.

Keywords

  • Epstein Barr Virus
  • Tumour Lysis Syndrome
  • Palliative Care Team
  • Mulago Hospital
  • Bone Marrow Disease

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-1-4614-4313-1_6
  • Chapter length: 25 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   129.00
Price excludes VAT (USA)
  • ISBN: 978-1-4614-4313-1
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   169.99
Price excludes VAT (USA)
Hardcover Book
USD   199.99
Price excludes VAT (USA)
Learn about institutional subscriptions
Fig. 6.1
Fig. 6.2
Fig. 6.3
Fig. 6.4
Fig. 6.5
Fig. 6.6
Fig. 6.7
Fig. 6.8
Fig. 6.9
Fig. 6.10

References

  1. Burkitt D (1958) A sarcoma involving the jaws in African children. Br J Surg 46(197):218–223

    PubMed  CrossRef  CAS  Google Scholar 

  2. O’Conor GT, Davies JN (1960) Malignant tumors in African children. With special reference to malignant lymphoma. J Pediatr 56:526–535

    PubMed  CrossRef  Google Scholar 

  3. Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt’s lymhoma. Lancet 1(7335):702–703

    PubMed  CrossRef  CAS  Google Scholar 

  4. Burkitt D (1962) A “tumour safari” in East and Central Africa. Br J Cancer 16:379–386

    PubMed  CrossRef  CAS  Google Scholar 

  5. Burkitt D (1962) Determining the climatic limitations of a children’s cancer common in Africa. Br Med J 2(5311):1019–1023

    PubMed  CrossRef  CAS  Google Scholar 

  6. Cook-Mozaffari P, Newton R, Beral V et al (1998) The geographical distribution of Kaposi’s sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 78(11):1521–1528

    PubMed  CrossRef  CAS  Google Scholar 

  7. Rainey JJ, Mwanda WO, Wairiumu P et al (2007) Spatial distribution of Burkitt’s lymphoma in Kenya and association with malaria risk. Trop Med Int Health 12(8):936–943

    PubMed  CrossRef  Google Scholar 

  8. de-The G (1977) Is Burkitt’s lymphoma related to perinatal infection by Epstein-Barr virus? Lancet 1(8007):335–338

    PubMed  CrossRef  CAS  Google Scholar 

  9. Burkitt D (1963) A children’s cancer dependent on environment. 17th Annual Symposium on Fundamental Cancer Research in Viruses, Nucleic Acids and Cancer, pp 615–629

    Google Scholar 

  10. Cardy AH, Sharp L, Little J (2001) Burkitt’s lymphoma: a review of the epidemiology. Kuwait Med J 33:293–306

    Google Scholar 

  11. Orem J, Mbidde EK, Lambert B et al (2007) Burkitt’s lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci 7(3):166–175

    PubMed  Google Scholar 

  12. Hesseling P, Molyneux E, Kamiza S et al (2009) Endemic Burkitt lymphoma: a 28-day treatment schedule with cyclophosphamide and intrathecal methotrexate. Ann Trop Paediatr 29(1):29–34

    PubMed  CrossRef  CAS  Google Scholar 

  13. Magrath IT (1991) African Burkitt’s lymphoma. History, biology, clinical features, and treatment. Am J Pediatr Hematol Oncol 13(2):222–246

    PubMed  CrossRef  CAS  Google Scholar 

  14. Mbulaiteye SM, Biggar RJ, Bhatia K et al (2009) Sporadic childhood Burkitt lymphoma incidence in the United States during 1992–2005. Pediatr Blood Cancer 53(3):366–370

    PubMed  CrossRef  Google Scholar 

  15. Mwando OW, Rochford R, Moorman AM et al (2004) Burkitt lymphoma in Kenya: geographical, age, gender and ethnic distribution. East Afr Med J 8:68–77

    Google Scholar 

  16. Owuru L, Yebonh FA, Osei-Akolo A (2010) Clinical and epidemiological characteristics of Burkitt’s lymphoma: an eight year case study at Komfor Anokye teaching hospital Ghana. Br J Biomed Sci 87:9–14

    Google Scholar 

  17. Newton R, Ziegler J, Beral V et al (2001) A case–control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer 92(5):622–627

    PubMed  CrossRef  CAS  Google Scholar 

  18. Sinfield RL, Molyneux EM, Banda K et al (2007) Spectrum and presentation of pediatric malignancies in the HIV era: experience from Blantyre, Malawi, 1998–2003. Pediatr Blood Cancer 48(5):515–520

    PubMed  CrossRef  CAS  Google Scholar 

  19. Orem J, Maganda A, Mbidde EK et al (2009) Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infection. Pediatr Blood Cancer 52(4):455–458

    PubMed  CrossRef  Google Scholar 

  20. Chintu C, Athale UH, Patil PS (1995) Childhood cancers in Zambia before and after the HIV epidemic. Arch Dis Child 73(2):100–104

    PubMed  CrossRef  CAS  Google Scholar 

  21. Mutalima N, Molyneux E, Jaffe H et al (2008) Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case–control study. PLoS One 3(6):e2505

    PubMed  CrossRef  Google Scholar 

  22. MacNeil A, Sumba OP, Lutzke ML et al (2003) Activation of the Epstein-Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli. Br J Cancer 88(10):1566–1569

    PubMed  CrossRef  CAS  Google Scholar 

  23. van den Bosch CA (2004) Is endemic Burkitt’s lymphoma an alliance between three infections and a tumour promoter? Lancet Oncol 5(12):738–746

    PubMed  CrossRef  Google Scholar 

  24. Tabuti JR, Dhillion SS, Lye KA (2003) Ethnoveterinary medicines for cattle (Bos indicus) in Bulamogi county, Uganda: plant species and mode of use. J Ethnopharmacol 88(2–3):279–286

    PubMed  CrossRef  Google Scholar 

  25. Shiramizu B, Barriga F, Neequaye J et al (1991) Patterns of chromosomal breakpoint locations in Burkitt’s lymphoma: relevance to geography and Epstein-Barr virus association. Blood 77(7):1516–1526

    PubMed  CAS  Google Scholar 

  26. Pelicci PG, Knowles DM, Magrath I et al (1986) Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 83(9):2984–2988

    PubMed  CrossRef  CAS  Google Scholar 

  27. Bellan C, Lazzi S, Hummel M et al (2005) Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 106(3):1031–1036

    PubMed  CrossRef  CAS  Google Scholar 

  28. Mwando OW (2004) Aspects of epidemiological and clinical features of patients with central nervours system Burkitt’s lymphoma in Kenya. East Afr Med J 8(suppl):897–903

    Google Scholar 

  29. Israels T, van de Wetering MD, Hesseling P (2009) Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi. Pediatr Blood Cancer 53(1):47–52

    PubMed  CrossRef  Google Scholar 

  30. Unicef (2011) The State of the World’s Children 2011

    Google Scholar 

  31. Nelson M, Perkins SL, Dave BJ et al (2010) An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children’s Oncology Group study CCG-5961. Br J Haematol 148(4):600–610

    PubMed  CrossRef  Google Scholar 

  32. Jaffe ES, Harris NL, Stein H et al (2001) WHO classification. Tumours of haematopoietic and lymphoid tissues. Lyon

    Google Scholar 

  33. van Noorden S, Lampert IA, Xue SA et al (2011) Burkitt’s lymphoma: maximising the use of fine needle aspirates by long-term preservation for diagnosis and research. Trans R Soc Trop Med Hyg 105(2):86–94

    PubMed  CrossRef  Google Scholar 

  34. Hesseling P, Broadhead R, Mansvelt E et al (2005) The 2000 Burkitt lymphoma trial in Malawi. Pediatr Blood Cancer 44(3):245–250

    PubMed  CrossRef  Google Scholar 

  35. Hesseling PB, Molyneux E, Tchintseme F et al (2008) Treating Burkitt’s lymphoma in Malawi, Cameroon, and Ghana. Lancet Oncol 9(6):512–513

    PubMed  CrossRef  Google Scholar 

  36. Patte C, Auperin A, Michon J et al (2001) The Societe Francaise d’Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 97(11):3370–3379

    PubMed  CrossRef  CAS  Google Scholar 

  37. Oettgen HF, Burkitt D, Burchenal JH (1963) Malignant lymphoma involving the jaw in African children: treatment with Methotrexate. Cancer 16:616–623

    PubMed  CrossRef  CAS  Google Scholar 

  38. Burkitt D, Hutt MS, Wright DH (1965) African lymphoma: preliminary observations on response to therapy. Cancer 18:399–410

    PubMed  CrossRef  CAS  Google Scholar 

  39. Clifford P (1968) Treatment of Burkitt’s lymphoma. Lancet 1(7542):599

    PubMed  CrossRef  CAS  Google Scholar 

  40. Morrow RH, Pike MC, Kisuule A (1967) Survival of Burkitt’s lymphoma patients in Mulago Hospital, Uganda. Br Med J 4(5575):323–327

    PubMed  CrossRef  CAS  Google Scholar 

  41. Ziegler JL, Morrow RH, Fass L et al (1970) Treatment of Burkitt’s tumor with cyclophosphamide. Cancer 26(2):474–484

    PubMed  CrossRef  CAS  Google Scholar 

  42. Nkrumah FK, Perkins IV, Biggar RJ (1977) Combination chemotherapy in abdominal Burkitt’s lymphoma. Cancer 40(4):1410–1416

    PubMed  CrossRef  CAS  Google Scholar 

  43. Magrath I (1990) Small non-cleaved lymphoma. In: The non-Hodgkin’s lymphoma. Edward Arnold, London, p 256

    Google Scholar 

  44. Murphy SB (1980) Classification, staging and end results of treatment of childhood non-Hodgkin’s lymphomas, dissimilarities from lymphomas in adults. Semin Oncol 7:332–339

    PubMed  CAS  Google Scholar 

  45. Patte C, Auperin A, Gerrard M et al (2007) Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood 109(7):2773–2780

    PubMed  CAS  Google Scholar 

  46. Patte C, Michon J, Frappaz D et al (1994) Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults. Baillieres Clin Haematol 7(2):339–348

    PubMed  CrossRef  CAS  Google Scholar 

  47. Burkitt D (1967) Long-term remissions following one and two-dose chemotherapy for African lymphoma. Cancer 20(5):756–759

    PubMed  CrossRef  CAS  Google Scholar 

  48. Ziegler JL, DeVita VT, Graw RG Jr et al (1976) Combined modality treatment of American Burkitt’s lymphoma. Cancer 38(6):2225–2231

    PubMed  CrossRef  CAS  Google Scholar 

  49. Link MP, Shuster JJ, Donaldson SS et al (1997) Treatment of children and young adults with early-stage non-Hodgkin’s lymphoma. N Engl J Med 337(18):1259–1266

    PubMed  CrossRef  CAS  Google Scholar 

  50. Ziegler JL, Bluming AZ (1971) Intrathecal chemotherapy in Burkitt’s lymphoma. Br Med J 3(5773):508–512

    PubMed  CrossRef  CAS  Google Scholar 

  51. Traore F, Coze C, Atteby JJ et al (2011) Cyclophosphamide monotherapy in children with Burkitt lymphoma: a study from the French-African Pediatric Oncology Group (GFAOP). Pediatr Blood Cancer 56(1):70–76

    PubMed  CrossRef  Google Scholar 

  52. Hesseling PB, Njume E, Kouya F, Katayi T, Wharin P, Tamannai M, et al. The Cameroon 2008 Burkitt lymphoma protocol: improved event-free survival with treatment adapted to disease stage and the response to induction therapy. Pediatr Hematol Oncol 2012 Mar;29(2):119–129

    PubMed  CrossRef  CAS  Google Scholar 

  53. Hesseling PB (2000) The SIOP burkitt lymphoma pilot study in Malawi, Africa. Med Pediatr Oncol 34(2):142

    PubMed  CrossRef  CAS  Google Scholar 

  54. Harif M, Barsaoui S, Benchekroun S et al (2008) Treatment of B-cell lymphoma with LMB modified protocols in Africa – report of the French-African Pediatric Oncology Group (GFAOP). Pediatr Blood Cancer 50(6):1138–1142

    PubMed  CrossRef  Google Scholar 

  55. El Kababri M, Mrimi F, Loumatine K (2009) Treatment of childhood Burkitt lymphoma in North Africa: a study of the French-African Pediatric Oncology Group (G.F.A.O.P.). Hematology Meeting Reports 3:5:88

    Google Scholar 

  56. Ahmad N, Zaidi A, Badar F et al (2010) Clinical characteristics and outcome analysis of pediatric B-cell non-Hodgkin’s lymphoma. Experience with FAB-LMB 96 and UKCCSG B-cell NHL guidelines in a developing country. Asia Pac J Clin Oncol 6(1):49–56

    PubMed  CrossRef  Google Scholar 

  57. Wessels G, Hesseling PB (2000) High-dose intense chemotherapy in South African children with B-cell lymphoma: morbidity, supportive measures and outcome. Med Pediatr Oncol 34:143–146

    CrossRef  Google Scholar 

  58. Moleti ML, Al-Hadad SA, Al-Jadiry MF et al (2011) Treatment of children with B-cell non-Hodgkin lymphoma in a low-income country. Pediatr Blood Cancer 56:560–567

    PubMed  CrossRef  Google Scholar 

  59. Katona P, Katona-Apte J (2008) The interaction between nutrition and infection. Clin Infect Dis 46(10):1582–1588

    PubMed  CrossRef  Google Scholar 

  60. Sala A, Pencharz P, Barr RD (2004) Children, cancer, and nutrition – a dynamic triangle in review. Cancer 100(4):677–687

    PubMed  CrossRef  Google Scholar 

  61. Manary MJ (2006) Local production and provision of ready-to-use therapeutic food (RUTF) spread for the treatment of severe childhood malnutrition. Food Nutr Bull 27(3 Suppl):S83–S89

    PubMed  Google Scholar 

  62. Collins JJ (2001) Cancer pain management in children. Eur J Pain 5(Suppl A):37–41

    PubMed  CrossRef  CAS  Google Scholar 

  63. Nkrumah FK, Perkins IV (1976) Burkitt’s lymphoma: a clinical study of 110 patients. Cancer 37(2):671–676

    PubMed  CrossRef  CAS  Google Scholar 

  64. Phillips JA, Griffin BE (2007) Pilot study of sodium phenylbutyrate as adjuvant in cyclophosphamide-resistant endemic Burkitt’s lymphoma. Trans R Soc Trop Med Hyg 101(12):1265–1269

    PubMed  CrossRef  CAS  Google Scholar 

  65. Stimson L, Wood V, Khan O et al (2009) HDAC inhibitor-based therapies and haematological malignancy. Ann Oncol 20(8):1293–1302

    PubMed  CrossRef  CAS  Google Scholar 

  66. Pena A, Ortiz A, Gamboa A, Garrido C (2009) Preliminary results of a multicenter BFM-based study for B-cell malignancies in Central America. Hematology Meeting Reports 3:5:90

    PubMed  CrossRef  CAS  Google Scholar 

  67. Klumb CE, Apa AG, Carrico MK (2009) Long-term outcome of children with B-non-Hodgkin’s lymphoma: results from Brazilian National Cancer Institute. Hematology Meeting Reports 3:5:15

    PubMed  CrossRef  CAS  Google Scholar 

  68. Chantada G, Zubizarreta P, Felice MS et al (2009) Results of a modified BFM strategy for the treatment of B-cell malignancies in Argentina. 3:5: 26

    PubMed  CrossRef  CAS  Google Scholar 

  69. Woessmann W, Seidemann K, Mann G et al (2005) The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood 105(3):948–958

    PubMed  CrossRef  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Paediatric Department, College of Medicine, Queen Elizabeth Central Hospital, 360, Blantyre, Malawi, C.Africa

    Elizabeth Molyneux

  2. Department of Pediatric Oncology, VU University Medical Center, Amsterdam, The Netherlands

    Trijn Israels

  3. Princess Margaret Hospital for Children, Perth, Western Australia

    Thomas Walwyn

Authors
  1. Elizabeth Molyneux
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Trijn Israels
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas Walwyn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth Molyneux .

Editor information

Editors and Affiliations

  1. Perelman School of Medicine, University of Pennsylvania, Hamilton Walk 3610, Philadelphia, 19104, Pennsylvania, USA

    Erle S. Robertson

Rights and permissions

Reprints and Permissions

Copyright information

© 2013 Springer New York

About this chapter

Cite this chapter

Molyneux, E., Israels, T., Walwyn, T. (2013). Endemic Burkitt’s Lymphoma. In: Robertson, E. (eds) Burkitt’s Lymphoma. Current Cancer Research. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4313-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-4313-1_6

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-4312-4

  • Online ISBN: 978-1-4614-4313-1

  • eBook Packages: MedicineMedicine (R0)